Rumours swirl about TOWER Life sale
Over the past year it has sold both its investment and medical businesses.
In November, it sold its medical business to Australian listed company nib for $102 million. Last month, it sold its investment business, including its default KiwiSaver scheme, to Fisher Funds for $79 million – a deal that Fidelity Life had also been rumoured to have been interested in.
Speculation is mounting that TOWER will make more annoucements about its future and other asset sales at its annual meeting which is scheduled to be held in Auckland on March 21.
Advisers expect TOWER to sell the life insurance side of its business because it has not been re-investing in it and has not released any new products for some time. Also uncertainty about its future ownership is likely to impact on advisers' willingness to put business its way.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.